NCT04172571
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Liver Diseases
Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.
8,379 public trials
1,304 recruiting studies
Liver Diseases trial results
Completed
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
NCT03987451
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Arizona Liver Health Chandler, Arizona, United States
- The Institute for Liver Health dba Arizona Liver Health Peoria, Arizona, United States
- Southern California Research Center Coronado, California, United States
- Altman Clinical Translational Research Institute La Jolla, California, United States
NCT03776123
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +21 more
- Locations
-
- Korea University Ansan Hospital Ansan, South Korea
- Hallym University Sacred Heart Hospital Anyang, South Korea
- DONG-A University Hospital (Site A) Busan, South Korea
- DONG-A University Hospital (Site B) Busan, South Korea
NCT02109146
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Completed
Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
NCT06431438
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University Nanjing, Jiangsu, China
NCT03813953
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +4 more
- Locations
-
- NHS Lothian Edinburgh, United Kingdom
NCT01353911
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Completed
cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria
NCT04842565
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Zhongshan Hospital Shanghai, Shanghai Municipality, China
NCT04152343
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT03211208
- Conditions
- Actinomycetales Infections, Anti-Tuberculous Drug Reaction, Bacterial Infections, +12 more
- Locations
-
- Royal Infirmary Edinburgh Edinburgh, United Kingdom